Chardan Capital


Chardan Capital Initiates Buy on Amicus Therapeutics, Inc. (FOLD); Sees 14% Upside for the Stock

In a research report issued today, Chardan Capital analyst Gbola Amusa initiated coverage on shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) with a Buy rating …

Chardan Capital Slashes Price Target for OHR Pharmaceutical Inc Following Clinical Trial Setback

In a research note published after market close today, Chardan Capital analyst Gbola Amusa maintained a Neutral rating on OHR Pharmaceutical Inc (NASDAQ:OHRP) and reduced …

Chardan Capital Initiates Buy on Regeneron Pharmaceuticals Inc; Sees 15% Upside For The Stock

In a research report issued Friday, Chardan Capital analyst Gbola Amusa initiated coverage on shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) with a Buy rating and a price target …

Chardan Capital Reiterates Buy on La Jolla Pharmaceutical Company Following 4Q:14 Update

In a research report published Tuesday, Chardan Capital analyst Gbola Amusa reiterated a Buy rating on La Jolla Pharmaceutical Company (NASDAQ:LJPC) with a $54 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts